Multipotent Mesenchymal Stromal Cells for the Prophylaxis of Acute Graft-versus-Host Disease—A Phase II Study
The efficacy and the safety of the administration of multipotent mesenchymal stromal cells (MMSCs) for acute graft-versus-host disease (aGVHD) prophylaxis following allogeneic hematopoietic cell transplantation (HSCT) were studied. This prospective clinical trial was based on the random patient allo...
Main Authors: | Larisa A. Kuzmina, Natalia A. Petinati, Elena N. Parovichnikova, Lidia S. Lubimova, Elena O. Gribanova, Tatjana V. Gaponova, Irina N. Shipounova, Oxana A. Zhironkina, Alexey E. Bigildeev, Daria A. Svinareva, Nina J. Drize, Valery G. Savchenko |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2012/968213 |
Similar Items
-
Treatment of acute host-versus-graft reaction in patients after allogeneic hematopoietic cell transplantation with multipotent mesenchymal stromal cells from a bone marrow donor
by: N A Petinati, et al.
Published: (2012-07-01) -
Multipotent mesenchymal stromal cells application for acute graft versus host disease treatment
by: L. A. Kuzmina, et al.
Published: (2020-09-01) -
Characteristics of stromal cell precursors in patients after allogeneic bone marrow transplantation
by: N A Petinati, et al.
Published: (2013-12-01) -
Recovery of Donor Hematopoiesis after Graft Failure and Second Hematopoietic Stem Cell Transplantation with Intraosseous Administration of Mesenchymal Stromal Cells
by: Nataliya Petinati, et al.
Published: (2018-01-01) -
THE EFFICACY OF POSACONAZOLE FOR PROPHYLAXIS OF INVASIVE MYCOSES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
by: G. A. Klyasova, et al.
Published: (2017-11-01)